HIF1A and neoplasm: This pathway has been studied extensively in the context of cancer, as hypoxic tumour environments can activate HIF-1, the heterodimeric protein consisting of the HIF-1⍺ and HIF-1β subunits, to promote cell proliferation by increasing glycolysis [72] and vasodilation [73].